Outcomes with Simultaneous Administration of Mifepristone and Misoprostol for Early Medical Abortion
with Patricia Lohr, MD MPH, BPAS Medical Director and BSACP Treasurer
Thursday 14 December 2017 at 6:30 PM GMT / 1:30 PM EST
This joint webinar with the British Society of Abortion Care Providers (BSACP) and Association of Reproductive Health Professionals (ARHP) is the first of a new series of members-only educational opportunities. We will provide several of these webinars throughout the year at no cost to BSACP/ARHP members, so although this inaugural webinar is open to non-members, we encourage you to join BSACP or renew your membership for 2018 to participate in future activities.
[NB. BSACP will shortly be contacting current members individually about membership renewal arrangements for 2018.]
In this webinar, Dr Patricia Lohr, Medical Director of British Pregnancy Advisory Service, will discuss reduced-interval medical abortion regimens including outcomes from a large cohort study comparing simultaneous dosing with a 24–48 hour interval. As legislative restrictions continue to affect the provision of medically-induced abortion, reduced interval regimens offer an opportunity to protect patients’ access to care but at the expense of greater effectiveness.
By the end of this activity, participants will be able to:
1. Identify the primary impact of legislative restrictions on medical abortion care
2. Explain the rationale for reduced interval medical abortion regimens
3. Describe the effectiveness and acceptability of reduced-interval medical abortion regimens
4. Compare outcomes using simultaneous administration of mifepristone and misoprostol to those using a regimen with a 24- to 48-hour interval between medications.
Register NOW by clicking: https://register.gotowebinar.com/register/5452575305632583171
We hope you will consider joining us for this FREE webinar and future ARHP/BSACP activities.
Kate Guthrie/Joanne Fletcher (BSACP Co-Chairs)